Orakris Medsolutions Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 29-06-2024
- Paid Up Capital ₹ 0.50 M
as on 29-06-2024
- Company Age 16 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -83.98%
(FY 2018)
- Profit -204.63%
(FY 2018)
- Ebitda -870.36%
(FY 2018)
- Net Worth -105.36%
(FY 2018)
- Total Assets -11.46%
(FY 2018)
About Orakris Medsolutions
The Company is engaged in the Business Outsourcing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Divya Intha and Vijaya Reddy serve as directors at the Company.
- CIN/LLPIN
U45400TG2008PTC059055
- Company No.
059055
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 May 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Orakris Medsolutions Private Limited offer?
Orakris Medsolutions Private Limited offers a wide range of products and services, including Health Care Service, Medical Consultants & Clinics, Medical Consultancy Services, Content Writing Service, Research Development Services.
Who are the key members and board of directors at Orakris Medsolutions?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Divya Intha  | Director | 08-May-2008 | Current |
| Vijaya Reddy | Whole-Time Director | 21-Oct-2009 | Current |
Financial Performance and Corporate Structure Insights of Orakris Medsolutions.
Orakris Medsolutions Private Limited, for the financial year ended 2018, experienced significant reduction in revenue, with a 83.98% decrease. The company also saw a substantial fall in profitability, with a 204.63% decrease in profit. The company's net worth observed a substantial decline by a decrease of 105.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Orakris Medsolutions?
In 2019, Orakris Medsolutions had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Bridge Health Life Sciences Private LimitedActive 14 years 4 months
Divya Intha and Vijaya Reddy are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Orakris Medsolutions?
Unlock and access historical data on people associated with Orakris Medsolutions, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Orakris Medsolutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Orakris Medsolutions's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
